Radiotherapy improves the clinical outcomes of recurrent or metastatic head and neck cancers treated with immunotherapy
Abstract Background It is uncertain whether the combination of immunotherapy and radiotherapy can provide survival benefits for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). Methods We retrospectively analyzed the impact of radiotherapy on the efficacy of immunotherapy and...
Saved in:
| Main Authors: | Yanshuang Cheng, Juan Wang, Ji Sun, Yahua Zhong, Qiuji Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-06-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02801-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Survival analysis of patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed radiotherapy and immunotherapy
by: Peng Xu, et al.
Published: (2025-03-01) -
Indian clinical practice consensus guidelines for the management of recurrent, persistent, or metastatic squamous cell carcinoma of head-and-neck - Update 2023
by: Vanita Noronha, et al.
Published: (2024-11-01) -
Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01) -
Advances and challenges in immunotherapy in head and neck cancer
by: Hazem Aboaid, et al.
Published: (2025-06-01) -
Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
by: Sandra Llop, et al.
Published: (2024-11-01)